高分子量激肽原促进镰状细胞病小鼠模型的早期死亡和肾功能障碍
该研究在Townes镰状细胞病小鼠模型中探究高分子量激肽原(HK)的作用,发现镰状细胞病患者血浆裂解HK水平升高,提示HK激活;短期HK缺乏减轻稳态镰状小鼠的凝血酶生成和炎症,且不依赖缓激肽信号;长期HK缺乏减轻肾损伤、减少慢性炎症并最终改善镰状小鼠生存。
要点
- 镰状细胞病患者血浆裂解HK水平较健康对照升高,提示HK持续激活。
- 短期HK缺乏减轻稳态镰状小鼠的凝血酶生成和炎症,不依赖缓激肽信号。
- 长期HK缺乏减轻镰状小鼠肾损伤、减少慢性炎症并改善生存。
核心结论
- HK参与镰状细胞病小鼠的高凝和促炎状态,长期HK缺乏可减轻肾损伤、减少慢性炎症并改善生存。
研究设计与样本
- 研究采用Townes镰状细胞病小鼠模型,通过骨髓移植在HK缺陷背景上生成野生型和镰状细胞小鼠,并检测镰状细胞病患者与健康对照的血浆裂解HK水平。
主要发现
- 镰状细胞病患者血浆裂解HK水平较健康对照升高,提示镰状细胞病中存在持续的HK激活。
- 短期HK缺乏减轻稳态镰状小鼠的凝血酶生成和炎症,且该效应不依赖缓激肽信号。
- 长期HK缺乏减轻镰状小鼠肾损伤、减少慢性炎症并最终改善生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sickle cell disease (SCD) is characterized by chronic hemolytic anemia, vaso-occlusive crises, chronic inflammation, and activation of coagulation. The clinical complications such as painful crisis, stroke, pulmonary hypertension, nephropathy and venous thromboembolism lead to cumulative organ damage and premature death. High molecular weight kininogen (HK) is a central cofactor for the kallikrein-kinin and intrinsic coagulation pathways, which contributes to both coagulation and inflammation. OBJECTIVE: We hypothesize that HK contributes to the hypercoagulable and pro-inflammatory state that causes end-organ damage and early mortality in sickle mice. METHODS: We evaluated the role of HK in the Townes mouse model of SCD. RESULTS/CONCLUSIONS: We found elevated plasma levels of cleaved HK in sickle patients compared to healthy controls, suggesting ongoing HK activation in SCD. We used bone marrow transplantation to generate wild type and sickle cell mice on a HK-deficient background. We found that short-term HK deficiency attenuated thrombin generation and inflammation in sickle mice at steady state, which was independent of bradykinin signaling. Moreover, long-term HK deficiency attenuates kidney injury, reduces chronic inflammation, and ultimately improves survival of sickle mice.
引用
- Sparkenbaugh EM, Kasztan M, Henderson MW, et al. High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease. J Thromb Haemost. 2020. PMID: 32573897. doi:10.1111/jth.14972
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。